Consumer interest in health, wellness and the importance of nutrition continues to grow. During my first few months here, I have become convinced that Raisio is well placed to benefit from this change: Raisio boasts an exceptionally strong combination of research expertise, well-known consumer brands and the ability to combine delicious taste and convenience with scientifically proven health benefits.
I have come to this conclusion after familiarising myself with our operations after visiting our factories in Raisio and Nokia, as well as our subsidiaries in the UK, Ireland and Poland. At the same time, I have met with our personnel, customers and partners in various markets. These meetings have repeatedly highlighted Raisio’s clear strengths: strong brands, competitive expertise in oats, a sound financial position and committed personnel. I have been particularly impressed by our personnel’s ambition, expertise and desire to shape Raisio’s next phase of growth.
Net sales for January–September remained at the level of the comparison period at EUR 171.3 (169.0) million. Although net sales rose during the third quarter by 2.1% to EUR 57.8 (56.7) million, we cannot be satisfied with the current rate of growth. The figures show that the foundations for growth laid last year and the positive trend that has continued this year have not yet translated into sufficiently rapid growth. On a positive note, growth is being generated in a number of areas and our strategic projects are progressing, but we must ensure that we turn this momentum into stronger commercial success than we are currently achieving. Our profitability in the third quarter remained close to the comparison period, with comparable EBIT of EUR 8.4 million (8.6 million). Profitability in the Breakfast, Snacking & Food Solutions business was supported by sales growth and improved operational efficiency, while lower consumer sales volumes in the UK and adverse foreign exchange effects weighed on the profitability of the Heart Health business.Our ongoing ERP project also had a negative impact on the Group’s comparable EBIT.
In the Heart Health business, sales of spreads have fallen short of our targets in a market facing challenges from changing consumer habits and intensifying competition, amid a decline in margarine consumption. Meanwhile, the market growth of oat-based dairy alternatives has been slower than we had anticipated. For this reason, we are focusing even more strongly on increasing our market share, commercialising innovations and developing new sources of growth. We are currently assessing the implementation of our strategy, and in early 2027 we will refine our priorities in terms of accelerating growth, as well as the measures needed to strengthen our ability to implement our strategy.

Raisio boasts an exceptionally strong combination of research expertise, well-known consumer brands and the ability to combine delicious taste and convenience with scientifically proven health benefits.
Although the market environment remains challenging, I firmly believe in Raisio’s long-term prospects. Consumer interest in healthy, plant-based solutions that promote well-being continues to grow. We have strong brands, leading expertise in oats and a sound financial position, which will enable us to continue to capitalise on these opportunities in the years to come. At the same time, our innovation projects strengthen our ability to develop healthy food solutions for the future. Our research programme focusing on fibre innovations – one of our most strategically significant projects – is progressing as planned, and the commissioning of the associated pilot plant has begun. Furthermore, the construction of our new product development and research facilities is proceeding on schedule.
We are now refining the prioritisation of our strategic projects and focusing on ensuring that the foundations we have laid translate into faster growth and better results. Towards the end of the year, we will be focusing in particular on strengthening the growth of the Benecol® brand, driving forward the commercialisation of our innovation projects and ensuring the smooth roll-out of our ERP system. At the same time, we will continue to exercise strict cost control and actively assess opportunities to utilise our strong balance sheet to accelerate growth.
Elli Siltala
CEO, Raisio plc
November 2026